Tradestie Institutional Equity Comparison Engine

GRAL vs DGX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

DGX Overall Edge

DGX Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“3 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Quest Diagnostics Inc. (DGX) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus DGX at 21.9x Forward P/E and 14.9% operating margin (+10.0% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against DGX sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs DGX 21.9x Fwd P/E
Growth & Margin Winner DGX
Op Margin -332.0% vs 14.9% ยท YoY +3.7% vs +10.0%
Momentum & Technical Winner DGX
1Y +24.6% vs +39.8% ยท 52W Pos 51% vs 99%
Options & Structure Winner DGX
BREAKDOWN (53rd %ile IV) vs CONSOLIDATION (16th %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
DGX NYSE
Quest Diagnostics Inc.
Services-Medical Laboratories
$262.21
+1.01% 1D
Market Cap $28.6B
1M Return +11.58%
1Y Return +39.79%
Forward P/E 21.9x
Unified AI Score
41.1 / 100 SELL
Tech 21.0 Fund 37.0 Flow 55.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% DGX +39.79% Spread: +12.87 pp (DGX Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GRAL Revenue DGX Revenue GRAL Op. Margin DGX Op. Margin Margin Edge
FY2018 N/A $7.53B N/A 14.6% DGX
FY2019 N/A $7.73B N/A 15.9% DGX
FY2020 N/A $9.44B N/A 20.9% DGX
FY2021 N/A $10.8B N/A 22.1% DGX
FY2022 N/A $9.88B N/A 14.4% DGX
FY2023 $90M $9.25B -1627.6% 13.6% DGX
FY2024 $130M $9.87B -1743.0% 13.6% DGX
FY2025 $150M $11.0B -382.0% 14.1% DGX

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (3) vs DGX (7)
Institutional Metric GRAL DGX Criterion Row Winner
Market Capitalization Scale $5.2B $28.6B Larger Scale DGX
Trailing P/E Ratio Valuation 1.1x 25.9x Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x 21.9x Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% +10.0% Higher Growth DGX
Operating Margin (TTM) Profitability -332.0% 14.9% Higher Margin DGX
Net Profit Margin Profitability -243.8% 9.5% Higher Margin DGX
Return on Equity (ROE) Capital Efficiency -17.3% 15.3% Higher ROE DGX
52-Week Range Position Momentum 51% ($42โ€“$166) 99% ($171โ€“$263) Stronger Trend DGX
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol -0.06ฮฒ ยท 19% Vol Lower Realized Risk DGX
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 41.1 / 100 (SELL) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs DGX Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
DGX CONSOLIDATION
71d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live DGX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor DGX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.